-
@ South China Morning Post - by layer3.news
2025-05-19 04:10:08
nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqrfa20llezzw8sn2kxlz2erhss54yt3czlsh7xjjkvzn4k4z9fepsqtd8da
✍️ The global market for diabetes drugs used for treating obesity is expected to expand in Asia, with new players emerging to compete with giants Eli Lilly and Novo Nordisk.
👉 The global market for diabetes drugs used for treating obesity is expected to expand in Asia.
👉 New players are emerging to compete with giants Eli Lilly and Novo Nordisk.
👉 Several drug candidates are likely to be approved for commercial sales in the next five years.
👉 The market is expected to expand in Asia, particularly in China and Japan, where penetration is low and innovation continues to emerge.
#FrancisChowChun-chung #ThibaultBoutherin #Asia #China #Japan #HongKong #health
nostr:nevent1qvzqqqqqqypzqxn65llljyyu0px4vd7y4j80ppf2ghrs9lp0ud99vc98td2y2njrqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqv43207plwzmh59djqs4kx06s8pm0r0eydsrswuh820a4ddw5rrmqd3y7ys